Key result
Cross-trait genomic analysis identifies ~46 shared loci linking metabolic syndrome and CAD.
Why the study?
Genetic studies show genetic overlap between metabolic syndrome and coronary artery disease, indicating shared biological pathways.
Do shared genetic variants and tissue-specific gene expressions causally link metabolic syndrome traits with coronary artery disease?
Observational
Do shared genetic variants and tissue-specific gene expressions causally link metabolic syndrome traits with coronary artery disease?
p-value: p=<0.05
This genome-wide cross-trait analysis identifies shared pleiotropic genes (such as DDAH2, CYP21A2, and CAMK1D) between metabolic syndrome and coronary artery disease, highlighting potential targets for integrated therapeutic strategies.
Potential joint targets merit preclinical validation; leaves open clinical translation pending functional and trial confirmation.
Metabolic syndromes (MeS), marked by central obesity, high blood pressure, abnormal cholesterol and blood sugar, are key cardiovascular disease (especially coronary artery disease, CAD) risk factors. Genetic studies show MeS-CAD genetic overlap, indicating shared biological pathways. We used Summary-data-based Mendelian Randomization (SMR), Bayesian colocalization (with large GWAS summary stats for MeS/CAD and cis-eQTL data from 3 tissues) and Transcriptome-Wide Association Study (TWAS). We also investigated the effects of gene knockout on mouse phenotypes. SMR found 886/737/192 shared genes in blood/brain cortex/liver; colocalization identified 11/13/5 shared causal genes in these tissues and 46 shared loci (e.g., CAMK1D, OR=1.11; AGPAT1, OR=1.13; FDR<0.05). Moreover, knocking out these genes in mice affected metabolism, adipose tissue, cardiovascular function, glucose homeostasis, and the fat/muscle balance. This study identified common regulatory genes between MeS and CAD, suggesting that targeted therapies or interventions could potentially address both conditions simultaneously, offering prospects for more integrated treatment strategies.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2025) conducted an observational in Metabolic syndrome and Coronary artery disease. Shared genetic loci and gene expression vs. Baseline genetic risk was evaluated on Shared causal genes and loci between metabolic syndrome and coronary artery disease (identified via SMR and Bayesian colocalization) (p=<0.05). Genome-wide cross-trait analysis identified 46 shared genetic loci and common regulatory genes between metabolic syndrome and coronary artery disease, suggesting shared biological pathways and potential joint therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: